Gradual Weight Loss and Muscle Maintenance For those using GLP-1 drugs primarily for weight loss, microdosing might offer a more gradual weight loss experience, which some individuals believe helps preserve muscle mass
When in doubt, start a fresh vial
This matters because dosing errors are common, especially when working with multiple peptides at different concentrations
Ozempic is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) drug developed by pharmaceutical company Novo Nordisk
Crucially, the level of improvement was highest for the newest GLP-1 drugs, with tirzepatide performing best of all, consistent with Mounjaro and Zepbound patient reports
Elderly patients Older adults are at higher risk for hypoglycemia with insulin therapy, including Toujeo